Results 101 to 110 of about 377,839 (219)

Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]

Sultan Qaboos Univ Med J, 2022
Al-Qassabi AM, Al-Farsi F.
europepmc   +1 more source

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]

Public Health Pract (Oxf), 2023
Guo A, Leung J, Ayers T, Fields VS, Safi H, Waters C, Curns AT, Routh JA, Haselow DT, Marlow MA, Marin M.   +10 more
europepmc   +1 more source

Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination

Human Vaccines & Immunotherapeutics
This study compared the immunogenicity of the measles-mumps-rubella (MMR) vaccine when administered alone versus when co-administered with the rotavirus vaccine in infants aged 8–9 months.
Xue-Feng Liang, Xiao-Shu Zhang, Jing An, Yu Tang   +3 more
doaj   +1 more source

Prediction of Specific Antibody- and Cell-Mediated Responses Using Baseline Immune Status Parameters of Individuals Received Measles-Mumps-Rubella Vaccine. [PDF]

Viruses, 2023
Toptygina A, Grebennikov D, Bocharov G.
europepmc   +1 more source

Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study

Vaccines
In 2014, the Expanded Program on Immunization of Thailand changed the timing of the second dose of the measles–mumps–rubella (MMR) vaccine from 4–6 years to 2.5 years, while maintaining the first dose at 9 months of age.
Nasiri Sarawanangkoor, Nasamon Wanlapakorn, Donchida Srimuan, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Yong Poovorawan   +5 more
doaj   +1 more source

Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases. [PDF]

Oman Med J, 2022
Al-Qassabi AM, Al Kindi A.
europepmc   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know [Vietnamese]

MMR vaccine (measles, mumps, rubella) : what you need to know [Vietnamese]MMR VIS \u2013 Vietnamese (8/6/21)vietnamese_mmr ...

core  

Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage

Вопросы вирусологии
Introduction. The problem of vaccine-preventable infections requires assessing the state of herd immunity through serological monitoring. The aim. To study the epidemiological features of measles, rubella and mumps and to estimate their seroprevalence
Yana V. Simakova, Vladimir A. Gushchin, Tatiana A. Semenenko, Daria A. Ogarkova, Denis A. Kleymenov, Anna V. Nozdracheva, Victor A. Manuylov, Artem P. Tkachuk, Alexander L. Gintsburg   +8 more
doaj   +1 more source

MMR (measles-mumps-rubella) vaccine [PDF]

Paediatrics & Child Health, 2001
openaire   +2 more sources

The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine. [PDF]

J Infect Dis, 2022
Quach HQ, Chen J, Monroe JM, Ratishvili T, Warner ND, Grill DE, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +9 more
europepmc   +1 more source